Immix Biopharma (IMMX) Cash from Operations (2021 - 2026)
Immix Biopharma (IMMX) reported Cash from Operations of 9827193.0 for Q1 2026, down 483.17% on a YoY basis from 2564723.42 in Q1 2025, and up 10.9% sequentially from 11029607.0 in Q4 2025.
Immix Biopharma (IMMX) Cash from Operations (2021 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 6 years of Cash from Operations data on file, last reported at 9827193.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 483.17% year-over-year to 9827193.0; the trailing twelve-month figure through Mar 2026 stood at 32072357.0 (down 157.54% YoY), and the FY2025 full-year result was 23930304.0, down 63.96% from the prior year.
- Cash from Operations rose to 9827193.0 in Q1 2026, from 11029607.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 547066.0 in Q2 2022 to a low of 11029607.0 in Q4 2025.
- A 5-year average of 3948961.18 and a median of 3515346.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 2781.24% in 2022 and surged 55.97% in 2025, its largest moves.
- Tracing IMMX's Cash from Operations over 5 years: stood at 3903926.0 in 2022, then soared by 31.42% to 2677437.0 in 2023, then jumped by 44.87% to 1476198.0 in 2024, then slumped by 647.16% to 11029607.0 in 2025, then gained by 10.9% to 9827193.0 in 2026.
- Business Quant data shows IMMX's Cash from Operations at 9827193.0 in Q1 2026, 11029607.0 in Q4 2025, and 5905776.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Immix Biopharma | 487.25 Mn | 487.25 Mn | - | -9.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.83 Mn |
| Mar 31, 2026 | -9.83 Mn |
| Dec 31, 2025 | -11.03 Mn |
| Dec 31, 2025 | -11.03 Mn |
| Sep 30, 2025 | -5.91 Mn |
| Sep 30, 2025 | -5.91 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Mar 31, 2025 | -1.69 Mn |
| Mar 31, 2025 | -1.69 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | -4.04 Mn |
| Sep 30, 2024 | -4.04 Mn |
| Jun 30, 2024 | -5.26 Mn |
| Jun 30, 2024 | -5.26 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Dec 31, 2023 | -2.68 Mn |
| Dec 31, 2023 | -2.68 Mn |